Overview
Pharmaceutical dose form grouper concepts based on intended site of use for the dose form that are deemed to be clinically useful or which provide a helpful organizing grouper and that can be sufficiently defined may be included in the 736542009 |Pharmaceutical dose form (dose form)| hierarchy.
These concepts are used in modeling (medicinal product form) concepts in the International Release; they are not allowed to model (clinical drug) concepts in the International Release.
Modeling (stated view)
Pharmaceutical dose form grouper concepts based on intended site shall be modeled using the proximal primitive modeling pattern.
Parent concept | 736542009 |Pharmaceutical dose form (dose form) |
---|---|
Semantic tag | (dose form) |
Definition status | Defined |
Attribute: Has dose form intended site |
|
Naming Guidelines
FSN | Use the following pattern for the FSN; align naming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.
Example:
|
---|---|
Preferred Term | Use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.
Example:
|
Synonyms | Synonyms are not allowed unless explicitly identified as an exception in the Editorial Guidelines. |
Text definitions | Optional |
Exemplars
The following illustrates the stated view for grouper concept 740596000 |Cutaneous dose form (dose form)|:
The following illustrates the inferred view for grouper concept 740596000 |Cutaneous dose form (dose form)|:
The following illustrates the stated view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:
The following illustrates the inferred view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:
Feedback